Locke Lord advised Summit Midstream Corporation on the transaction, Kirkland & Ellis advised Tall Oak Midstream III and Tailwater Capital, and Gibson, Dunn & Crutcher advised...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised OneStream on the offering, Jones Day advised Kohlberg Kravis Roberts & Co. L.P. (“KKR”) and Latham & Watkins advised the...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised Planet Fitness, while White & Case has advised Guggenheim Securities, LLC, as structuring agent, on the offering. Planet Fitness announced a...
You must be a Standard 1 Year member to access this content.
Gornitzky represented the underwriters, led by TD Cowen and Guggenheim Securities on the offering. UroGen Pharma Ltd. secured a USD 107.5 million follow-on public offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised ProKidney, while Paul Hastings advised Jefferies, J.P. Morgan, and Guggenheim Securities, as joint book-running managers, in the transaction. ProKidney Corp. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Paul Weiss Rifkind Wharton & Garrison is advising Noble Corporation plc on the transaction, Kirkland & Ellis is advising Diamond Offshore Drilling, Inc. and Covington &...
You must be a Standard 1 Year member to access this content.
Skadden and Elvinger Hoss Prussen represented Intelsat in the transaction, and Gibson, Dunn & Crutcher and Hogan Lovells represented SES. Debevoise & Plimpton advised Guggenheim Securities...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
You must be a Standard 1 Year member to access this content.
